News
A new male contraceptive YCT-529 shows promise with a nonhormonal approach, preventing sperm production without altering ...
GSK’s Blenrep combinations receives Japanese approval for treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, May 20, 2025, 12:00 Hrs [IST] GSK plc announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback